<DOC>
	<DOCNO>NCT01597752</DOCNO>
	<brief_summary>The objective study determine biologic activity Blomia tropicalis allergen extract histamine equivalent prick ( HEP ) unit , order use in-house reference preparation ( IHRP ) .</brief_summary>
	<brief_title>Biological Standardization Blomia Tropicalis Allergen Extract</brief_title>
	<detailed_description>This open , unblinded non-randomized biological assay . The study design slight modification recommendation propose Nordic Guidelines . Four concentration Blomia tropicalis allergen extract , together positive negative control , use 10 mg/ml histamine dihydrochloride solution glycerinated phenol saline solution , respectively , test every patient duplicate volar surface forearm .</detailed_description>
	<criteria>1 . A documented positive case history inhalation allergy ( rhinitis and/or rhinoconjunctivitis and/or asthma ) relate Blomia tropicalis . 2 . Subject provide write informed consent , appropriately sign date subject ( legal representative , applicable ) . 3 . Subject male female race ethnic group . 4 . Age &gt; 18 year &lt; 50 year study inclusion day . 5 . Positive skin prick test standardize commercially available preparation Blomia tropicalis allergen extract . The skin prick test consider positive test result wheal major diameter least 3 mm least size positive control . Positive skin prick test result valid perform within one year prior inclusion subject study 6 . A positive test specific IgE Blomia tropicalis ( CAPRAST ≥ 2 ) . IgE result valid perform within one year prior inclusion subject study . 7 . Allergic symptom season Blomia tropicalis . 8 . Mean forearm major diameter wheal provoke histamine dihydrochloride ( 10 mg/ml ) ≥ 3 mm . 1 . Immunotherapy past 5 year allergen preparation know interfere allergen test ( e.g. , mite group extract ) . 2 . Use drug may interfere skin reaction ( e.g. , antihistamine ) . See Appendix 1 3 . Treatment follow medication : tricyclic tetracyclic antidepressant , βblockers corticosteroid ( &gt; 10 mg/day prednisone equivalent ) . 4 . Pregnancy . 5 . Dermographism affect skin area test site either study visit . 6 . Atopic dermatitis affect skin area test site either study visit . 7 . Urticaria affect skin area test site either study visit . 8 . Participation another clinical trial within last month . 9 . Subjects suffer pathology condition adrenalin contraindicate ( heart disease , severe hypertension , ... )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>Immunotherapy</keyword>
	<keyword>Skin prick test</keyword>
	<keyword>Standardization</keyword>
	<keyword>Blomia tropicalis</keyword>
</DOC>